Ireland· IE-PA-PA1613/002/001
Dysport 500 units Powder for solution for injection
A botulismus-antitoxin product containing clostridium botulinum toxin type a haemagglutinin complex, registered in Ireland by Ipsen Pharma. The same ATC class is registered in 4 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Botulismus-antitoxin is registered in 4 of 19 countries.
Countries holding a registration under ATC J06AA04 (botulismus-antitoxin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 3 of them publish a price we can compare per daily dose
Botulismus-antitoxin · ATC J06AA04
4 / 19 countries
- Czechiaprice
- Ireland
- Norwayprice
- Polandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Clostridium botulinum toxin type a haemagglutinin complex
- Manufacturer
- Ipsen Pharma
- Country
- Ireland (IE)
- ATC code
- J06AA04
- ATC class
- Botulismus-Antitoxin
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1613/002/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Botulismus-antitoxin in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBOTOXSportpharm LLC
- FinlandAlluzienceIpsen Pharma
- SwitzerlandAlluzience, InjektionslösungIPSEN Pharma Schweiz GmbH
- CzechiaALLUZIENCEIPSEN PHARMA S.A.S., Paříž
- PolandAlluzienceIpsen Pharma
- BelgiumAlluzience 200 Speywood-Eenheden/mlIpsen Pharma
- SpainALLUZIENCE 200 UNIDADES SPEYWOOD/ML SOLUCION INYECTABLEIpsen Pharma
- FranceALLUZIENCE 200 unités Speywood/mL, solution injectableIPSEN PHARMA
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Germany · Alluzience, Bocouture
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/20e6b240-d5fd-4d08-8a9e-e889a4935974 GET /v1/drugs/20e6b240-d5fd-4d08-8a9e-e889a4935974?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for injection",
"routes": [
"Not Currently Available"
],
"source": "hpra",
"atc_all": [
"J06AA",
"J06AA04"
],
"strength": null,
"pa_number": "PA1613/002/001",
"substances": [
"Clostridium botulinum toxin type a haemagglutinin complex"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "20/04/1994",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about botulismus-antitoxin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.